Orchid Pharma Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on Jun 26, 2025
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Orchid Pharma has notified the stock exchange about a Court Convened Meeting of shareholders scheduled for June 26, 2025. A Court Convened Meeting is called by an order of the National Company Law Tribunal (NCLT) or a High Court, typically to seek shareholders' approval on a specific matter such as a scheme of arrangement, merger, demerger, capital reduction, or restructuring. The exact agenda or proposal to be voted on was not disclosed in this filing, but shareholders should watch for the accompanying scheme document or explanatory statement that explains what resolution is being put to vote. This is a procedural compliance filing informing the exchange and public about the upcoming meeting.
Court Convened Meetings are usually tied to significant corporate actions like mergers, acquisitions, or restructuring. The outcome of this meeting could materially affect the company's capital structure or future operations, and shareholders should review the detailed scheme document once it is available to understand how the proposal may impact their holdings.